Delivery Order SPE2DB24D8003-SPE2DB25FJUMT
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of CONCERTA ER 54 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price of $6,476.13 and a performance period extending through November 29, 2023. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,600.58, is for the delivery of 100 units of CONCERTA ER 54 MG TABLET. This is a Firm Fixed Price delivery order contract with an ultimate completion date of April 3, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. government, particularly the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,060.46, is for the delivery of Concerta ER 27 mg tablets in quantities of 100. The contract has an ultimate completion date of January 3, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense, and holds a...
This federal contract award, valued at $7,561.86, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order without a set-aside designation, with a firm fixed-price pricing type and an ultimate completion date of December 17, 2024. The contract is for the delivery of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Concerta ER 36 mg tablets. The contract, valued at $7,494.21, is a firm fixed-price delivery order with an ultimate completion date of August 16, 2024. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999.00. This single-award IDC, part of the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $5,375.92, is for the delivery of 100 tablets of Concerta ER 54 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. Dakota Drug, Inc. holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This federal contract award to Dakota Drug, Inc. is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $12,427.91. The contract is for the delivery of Concerta ER 27 mg tablets, and is structured as a firm fixed-price agreement without any set-aside designation. Dakota Drug, Inc. is the prime contractor for this award, and is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company...
This federal contract award, valued at $5,353.16, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order (SPE2DB25FJTSA) under the larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...